Skip to content

Morpheus Nm-0354

by Blackrock Neuromed, LLC

Morpheus Nm-0354 is a Class II device made by Blackrock Neuromed, LLC, cleared under FDA 510(k) K071782 on 10 Jan 2008 and listed in FDA GUDID since 7 Dec 2016 (UDI-DI 00850154007079), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K071782

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850154007079 UDI-DI Date7 Dec 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Abbreviated NumberK071782 Date10 Jan 2008DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K071782 decided 10 Jan 2008 Active
  • FDA GUDID UDI-DI 00850154007079 listed 7 Dec 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K071782
  2. Listed FDA GUDID 00850154007079

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Morpheus
Generic name
Electroencephalography telemetric monitoring system
Model / Ref / Catalog
NM-0354
Primary DI / UDI-DI
00850154007079
510(k) Number
FDA product code
GWL, GWQ, OLV, GWK
GMDN term
Electroencephalography telemetric monitoring system
Device class
Class II
Regulation number
882.1835, 882.1400, 882.1845
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GWL (Amplifier, Physiological Signal).

Other devices from Blackrock Neuromed, LLC

See all devices from Blackrock Neuromed, LLC →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)